Takeda Pharmaceutical Company Limited Stock Börse Stuttgart
Stocks
TKD
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.12 EUR | -0.50% |
|
-4.10% | +12.28% |
| 07-30 | Keros Therapeutics to Receive $20 Million Development Milestone Payment From Takeda | DJ |
| 07-30 | Takeda Pharmaceutical Company Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
| Market Cap | 8,440B 53.57B 46.52B 43.37B 39.84B 75.35B 5,096B 76.18B 511B 200B 2,547B 201B 197B | P/E 2027 * |
42.4x | P/E 2028 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 12,373B 78.53B 68.19B 63.58B 58.4B 110B 7,470B 112B 750B 293B 3,734B 295B 288B | EV / Sales 2027 * |
2.65x | EV / Sales 2028 * | 2.57x |
| Free-Float |
99.28% | Yield 2027 * |
3.87% | Yield 2028 * | 3.96% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 week | -4.10% | ||
| Current month | -1.58% | ||
| 1 month | +3.28% | ||
| 3 months | +1.95% | ||
| 6 months | +0.17% | ||
| Current year | +12.28% |
| 1 week | 28.81 |  | 31.43 |
| 1 month | 28.17 | | 31.43 |
| 3 years | 23.07 | | 32.24 |
| 5 years | 23.07 | | 32.24 |
| 10 years | 23.07 | | 49.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2026-06-23 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 2024-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 2022-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 2015-05-31 |
Steven Gillis
BRD | Director/Board Member | 73 | 2018-12-31 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 2024-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.50% | -4.10% | +20.76% | +5.67% | 55.08B | |
| -0.58% | -8.71% | +44.91% | +147.91% | 1T | |
| +0.15% | -4.63% | +48.72% | +50.48% | 613B | |
| -0.57% | -7.32% | +23.71% | +65.13% | 433B | |
| +0.48% | -2.77% | +40.27% | +34.96% | 350B | |
| +0.08% | -4.45% | +31.74% | +39.89% | 292B | |
| +2.09% | -9.27% | +5.42% | +7.61% | 239B | |
| +1.75% | -8.29% | -1.73% | -42.05% | 206B | |
| +3.02% | -0.90% | +29.02% | +60.13% | 204B | |
| +2.83% | -0.02% | +17.27% | +70.68% | 163B | |
| Average | +1.06% | -3.88% | +26.01% | +44.04% | 388.94B | |
| Weighted average by Cap. | +0.43% | -4.34% | +33.54% | +69.81% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,668B 29.63B 25.73B 23.99B 22.04B 41.68B 2,818B 42.13B 283B 111B 1,409B 111B 109B | 4,747B 30.13B 26.16B 24.39B 22.41B 42.37B 2,866B 42.84B 288B 112B 1,433B 113B 111B |
| Net income | 191B 1.21B 1.05B 979M 900M 1.7B 115B 1.72B 11.55B 4.51B 57.52B 4.54B 4.44B | 316B 2.01B 1.74B 1.62B 1.49B 2.82B 191B 2.85B 19.15B 7.49B 95.4B 7.53B 7.37B |
| Net Debt | 3,932B 24.96B 21.67B 20.21B 18.56B 35.11B 2,374B 35.49B 238B 93.13B 1,187B 93.73B 91.67B | 3,779B 23.98B 20.82B 19.42B 17.84B 33.73B 2,281B 34.1B 229B 89.48B 1,140B 90.06B 88.09B |
| Date | Price | Change |
|---|---|---|
| 26-08-04 | €28.97 | -0.99% |
| 26-08-03 | €29.26 | -1.58% |
| 26-07-31 | €29.73 | -0.67% |
| 26-07-30 | €29.93 | -0.63% |
| 26-07-29 | €30.12 | -1.44% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
- TKD Stock
Select your edition
All financial news and data tailored to specific country editions
